Evaluation of Student Pharmacists’ Attitudes and Perceptions of Hormonal Contraception Prescribing in Indiana
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Sample
2.3. Data Collection
2.4. Data Analysis
3. Results
3.1. Education
3.2. Comfort with Prescribing
3.3. Concerns
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
- 1.
- What is your age?
- 2.
- What is your race?
- 3.
- What is your ethnicity?
- 4.
- How would you describe yourself?
- 5.
- In what year do you expect to receive your highest pharmacy degree (terminal degree)?
- 6.
- From what type of institution do you expect to receive your highest pharmacy degree (terminal degree)?
- 7.
- How would you best describe the pharmacy setting in which you are planning to practice the majority of the time?
- 8.
- How much do you agree with the following statement: “My pharmacy education included adequate teaching on contraception methods.”
- 9.
- How much do you agree with the following statement: “My pharmacy education included adequate teaching on contraception counseling.”
- 10.
- Other states such as Oregon, West Virginia, and Utah have expanded the scope of practice for pharmacists to include prescribing of contraception to women. Patients must complete a questionnaire regarding contraindications to hormonal contraceptive use and possible pregnancy status. Blood pressure is checked and certain counseling points are required. Do you believe a service like this would be beneficial in Indiana?
- 11.
- Why do you feel that pharmacist contraception prescribing would not be beneficial in Indiana? Select all that apply. (*Respondents only saw this question if they answered “No” to the previous question)
- 12.
- In an ideal setting where the scope of practice allows, and you had all of the necessary time, resources, training, and reimbursement, would you be interested in prescribing hormonal contraception?”
- 13.
- If no, why are you not interested in prescribing hormonal contraceptives? (select all that apply) (*Respondents only saw this question if they answered “No” to the previous question)
- 14.
- If allowed within the scope of practice for pharmacists in Indiana, how comfortable would you be prescribing and counselling on the following hormonal contraceptives?
Extremely Comfortable | Somewhat Comfortable | Neither Comfortable nor Uncomfortable | Somewhat Comfortable | Extremely Uncomfortable | |
Combined (estrogen/ progestin) oral pill | |||||
Progestin only oral pill | |||||
Transdermal (i.e., Xulane) | |||||
Injection (i.e., Depo-Provera) | |||||
Intravaginal (i.e., NuvaRing) | |||||
Intrauterine device (i.e., Mirena, Paragard) | |||||
Emergency contraception pill (i.e., ella, PlanB) |
- 15.
- What additional training would be necessary for you to prescribe contraception comfortably, if allowed within the scope for practice for pharmacists in Indiana?
- 16.
- Have you personally ever used hormonal contraception (i.e., pills, patch, vaginal ring, depo, IUD, implant)? (*Only respondents selecting that they identify as “Female” saw this question)
- 17.
- Have you personally ever experienced problems accessing hormonal contraception? (*Only respondents selecting that they identify as “Female” saw this question)
References
- Indiana State Department of Health. Statewide Standing Order for Tobacco Cessation Products. Available online: https://www.in.gov/pla/files/Statewide-Standing-Order-for-Tobacco-Cessation-Products-7.15.19.pdf (accessed on 5 November 2021).
- Guttmacher Institute. State Facts about Unintended Pregnancy: Indiana. Available online: https://www.guttmacher.org/sites/default/files/factsheet/in_18.pdf (accessed on 5 November 2021).
- Centers for Disease Control and Prevention. Women’s Health Statistics: Indiana. Available online: https://www.cdc.gov/reproductivehealth/data_stats/pdfs/indiana.pdf (accessed on 5 November 2021).
- Guttmacher Institute. Unintended Pregnancy in the United States. January 2019. Available online: https://www.guttmacher.org/sites/default/files/factsheet/fb-unintended-pregnancy-us.pdf (accessed on 5 November 2021).
- Overseas Development Institute. Barriers to Contraceptive Use. Available online: https://odi.org/en/about/our-work/barriers-to-contraceptive-use/ (accessed on 5 November 2021).
- Centers for Disease Control and Prevention. Get to Know YOUR Pharmacist. Available online: https://www.cdc.gov/heartdisease/pharmacist.htm (accessed on 5 November 2021).
- Gardner, J.S.; Downing, D.F.; Blough, D.K.; Miller, L.; Le, S.; Shotorbani, S. Pharmacist prescribing of hormonal contraceptives: Results of the Direct Access study. J. Am. Pharm. Assoc. 2008, 48, 212–226. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez, M.I.; Hersh, A.; Anderson, L.B.; Hartung, D.M.; Edelman, A.B. Association of Pharmacist Prescription of Hormonal Contraception with Unintended Pregnancies and Medicaid Costs. Obstet. Gynecol. 2019, 133, 1238–1246. [Google Scholar] [CrossRef] [PubMed]
- Landau, S.C.; Tapias, M.P.; McGhee, B.T. Birth control within reach: A national survey on women’s attitudes toward and interest in pharmacy access to hormonal contraception. Contraception 2006, 74, 463–470. [Google Scholar] [CrossRef] [PubMed]
- Meredith, A.H.; Wilkinson, T.A.; Vielott, T.L.; Meagher, C.G.; Ott, M.A. Expanding Adolescent Contraceptive Access to Pharmacies: Predictors of Adolescent Willingness to Utilize Pharmacist Prescribing. J. Am. Coll. Clin. Pharm. 2018, 1, 147. [Google Scholar]
- Wilkinson, T.A.; Miller, C.; Rafie, S.; Landau, S.C.; Rafie, S. Older teen attitudes toward birth control access in pharmacies: A qualitative study. Contraception 2018, 97, 249–255. [Google Scholar] [CrossRef] [PubMed]
- Foster, D.G.; Landau, S.C.; Monastersky, N.; Chung, F.; Kim, N.; Melton, M.; McGhee, B.T.; Stewart, F. Pharmacy access to emergency contraception in California. Perspect. Sex. Reprod. Health 2006, 38, 46–52. [Google Scholar] [CrossRef] [PubMed]
- Hilverding, A.T.; Mager, N.A.D. Pharmacists’ attitudes regarding provision of sexual and reproductive health services. J. Am. Pharm. Assoc. 2017, 57, 493–497. [Google Scholar] [CrossRef] [PubMed]
- Rafie, S.; Cieri-Hutcherson, N.E.; Frame, T.R.; Griffin, B.; Harris, J.B.; Horlen, C.; Shealy, K.; Stein, A.B.; Stone, R.H.; Vest, K.; et al. Pharmacists’ Perspectives on Prescribing and Expanding Access to Hormonal Contraception in Pharmacies in the United States. J. Pharm. Pract. 2021, 34, 230–238. [Google Scholar] [CrossRef] [PubMed]
- Rafie, S.; Kelly, S.; Gray, E.K.; Wong, M.; Gibbs, S.; Harper, C.C. Provider Opinions Regarding Expanding Access to Hormonal Contraception in Pharmacies. Women’s Health Issues 2016, 26, 153–160. [Google Scholar] [CrossRef] [PubMed]
- Rafie, S.; Haycock, M.; Rafie, S.; Yen, S.; Harper, C.C. Direct pharmacy access to hormonal contraception: California physician and advanced practice clinician views. Contraception 2012, 86, 687–693. [Google Scholar] [CrossRef] [PubMed]
- American College of Obstetricians and Gynecologists. Access to Contraception, Committee Opinion 615. January 2015 (Reaffirmed 2017). Available online: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2015/01/access-to-contraception (accessed on 5 November 2021).
- Rodriguez, M.I.; McConnell, K.J.; Swartz, J.; Edelman, A.B. Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision. J. Am. Pharm. Assoc. 2016, 56, 521–526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rafie, S.; Richards, E.; Rafie, S.; Landau, S.C.; Wilkinson, T.A. Pharmacist Outlooks on Prescribing Hormonal Contraception Following Statewide Scope of Practice Expansion. Pharmacy 2019, 7, 96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rodriguez, M.I.; Biel, F.M.; Swartz, J.J.; Anderson, L.; Edelman, A.B. Pharmacists’ experience with prescribing hormonal contraception in Oregon. J. Am. Pharm. Assoc. 2018, 58, 608–613. [Google Scholar] [CrossRef] [PubMed]
- Vu, K.; Rafie, S.; Grindlay, K.; Gutierrez, H.; Grossman, D. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California. J. Pharm. Pract. 2017, 32, 54–61. [Google Scholar] [CrossRef] [PubMed]
- Indiana House Bill 1379. 2020. Available online: https://legiscan.com/IN/research/HB1379/2020 (accessed on 5 November 2021).
- Rafie, S.; El-Ibiary, S.Y. Student pharmacist perspectives on providing pharmacy-access hormonal contraception services. J. Am. Pharm. Assoc. 2011, 51, 762–765. [Google Scholar] [CrossRef]
- Mospan, C.M.; Balenger, S.B.; Gillette, C. Student pharmacists’ perceptions regarding pharmacist-prescribed hormonal contraceptives and their professional responsibility. J. Am. Pharm. Assoc. 2021, 61, e145–e152. [Google Scholar] [CrossRef] [PubMed]
- Hohmann, N.; Kavookjian, J. Using the Theory of Planned Behavior to determine pharmacy students’ intention to participate in hormonal contraception counseling services. Curr. Pharm. Teach. Learn. 2018, 10, 1488–1495. [Google Scholar] [CrossRef]
- Emsi. How Your School Affects Where You Live. Available online: https://www.economicmodeling.com/how-your-school-affects-where-you-live/ (accessed on 5 November 2021).
- MacGowan, M.J.; Wong, S.E. Improving Student Confidence in Using Group Work Standards. Res. Soc. Work. Pract. 2017, 27, 434–440. [Google Scholar] [CrossRef]
- Rudavsky, S. Pharmacies Are Slow to Adopt State Policy Allowing Chantix without Prescription. Indiana Pharmacists Association. Available online: https://www.indianapharmacists.org/news/pharmacies-are-slow-to-adopt-new-state-policy-allowing-chantix-without-prescription/ (accessed on 5 November 2021).
n | % | |
---|---|---|
Age | ||
20–24 years old | 105 | 77.2% |
25–34 years old | 26 | 19.1% |
35–44 years old | 5 | 3.7% |
Race | ||
White | 121 | 89.0% |
Non-white | 15 | 11.0% |
Ethnicity | ||
Hispanic or Latino | 4 | 2.9% |
Non-Hispanic or Latino | 132 | 97.1% |
Gender | ||
Men | 30 | 22.1% |
Women | 105 | 77.2% |
Other | 1 | 0.7% |
Year in Pharmacy School | ||
Third year | 56 | 41.2% |
Fourth year | 80 | 58.8% |
Pharmacy School | ||
Public | 25 | 18.4% |
Non-public | 111 | 81.6% |
Career Interest | ||
Community a | 71 | 52.2% |
Hospital b | 65 | 47.8% |
Personal Use of Hormonal Contraceptives c | ||
Used before | 85 | 81.7% |
Never used | 19 | 18.3% |
Prefer not to answer | 0 | 0.0% |
Extremely Uncomfortable | Somewhat Uncomfortable | Neither Comfortable nor Uncomfortable | Somewhat Comfortable | Extremely Comfortable | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Combined Oral Pill | n | % | n | % | n | % | n | % | n | % |
All respondents | 4 | 3.0% | 12 | 8.9% | 7 | 5.7% | 48 | 35.6% | 64 | 47.4% |
Third-year students | 3 | 5.5% | 2 | 3.6% | 1 | 1.8% | 18 | 32.7% | 31 | 56.4% |
Fourth-year students | 1 | 1.3% | 10 | 12.5% | 6 | 7.5% | 30 | 37.5% | 33 | 41.3% |
Community | 1 | 1.4% | 6 | 8.6% | 3 | 4.3% | 24 | 34.3% | 36 | 51.4% |
Hospital | 3 | 4.6% | 6 | 9.2% | 4 | 6.2% | 24 | 36.9% | 28 | 43.1% |
Progestin-only Pill | ||||||||||
All respondents | 4 | 3.0% | 14 | 10.4% | 14 | 10.4% | 48 | 35.6% | 55 | 40.7% |
Third-year students | 3 | 5.5% | 3 | 5.5% | 2 | 3.6% | 20 | 36.4% | 27 | 49.1% |
Fourth-year students | 1 | 1.3% | 11 | 13.8% | 12 | 15.0% | 28 | 35.0% | 28 | 35.0% |
Community | 1 | 1.4% | 6 | 8.6% | 9 | 12.9% | 25 | 35.7% | 29 | 41.4% |
Hospital | 3 | 4.6% | 8 | 12.3% | 5 | 7.7% | 23 | 35.4% | 26 | 40% |
Transdermal Patch | ||||||||||
All respondents | 5 | 3.7% | 17 | 12.6% | 17 | 12.6% | 50 | 37.0% | 46 | 34.1% |
Third-year students | 3 | 5.5% | 5 | 9.1% | 1 | 1.8% | 25 | 45.5% | 21 | 38.2% |
Fourth-year students | 2 | 2.5% | 12 | 15.0% | 16 | 20.0% | 25 | 31.3% | 25 | 31.3% |
Community | 1 | 1.4% | 6 | 8.6% | 12 | 17.1% | 29 | 41.4% | 22 | 31.4% |
Hospital | 4 | 6.2% | 11 | 16.9% | 5 | 7.7% | 21 | 32.3% | 24 | 36.9% |
Injection | ||||||||||
All respondents | 5 | 3.7% | 21 | 15.6% | 16 | 11.9% | 50 | 37.0% | 43 | 31.9% |
Third-year students | 4 | 7.3% | 4 | 7.3% | 3 | 5.5% | 22 | 40.0% | 22 | 40.0% |
Fourth-year students | 1 | 1.3% | 17 | 21.3% | 13 | 16.3% | 28 | 35.0% | 21 | 26.3% |
Community | 1 | 1.4% | 9 | 12.9% | 9 | 12.9% | 25 | 35.7% | 26 | 37.1% |
Hospital | 4 | 6.2% | 12 | 18.5% | 7 | 10.8% | 25 | 38.5% | 17 | 26.2% |
Intravaginal Ring | ||||||||||
All respondents | 4 | 3.0% | 17 | 12.6% | 8 | 5.9% | 56 | 41.5% | 50 | 37.0% |
Third-year students | 3 | 5.5% | 4 | 7.3% | 1 | 1.8% | 21 | 38.2% | 26 | 47.3% |
Fourth-year students | 1 | 1.3% | 13 | 16.3% | 7 | 8.8% | 35 | 43.8% | 24 | 30.0% |
Community | 1 | 1.4% | 8 | 11.4% | 5 | 7.1% | 27 | 38.6% | 29 | 41.4% |
Hospital | 3 | 4.6% | 9 | 13.8% | 3 | 4.6% | 29 | 44.6% | 21 | 32.3% |
Intrauterine Device | ||||||||||
All respondents | 7 | 5.2% | 28 | 20.7% | 15 | 11.1% | 43 | 31.9% | 42 | 31.1% |
Third-year students | 4 | 7.3% | 7 | 12.7% | 5 | 9.1% | 13 | 23.6% | 26 | 47.3% |
Fourth-year students | 3 | 3.8% | 21 | 26.3% | 10 | 12.5% | 30 | 37.5% | 16 | 20.0% |
Community | 3 | 4.3% | 13 | 18.6% | 7 | 10% | 23 | 32.9% | 24 | 34.3% |
Hospital | 4 | 6.2% | 15 | 23.1% | 8 | 12.3% | 20 | 30.8% | 18 | 27.7% |
Emergency Contraception | ||||||||||
All respondents | 7 | 5.2% | 8 | 5.9% | 5 | 3.7% | 46 | 34.1% | 69 | 51.5% |
Third-year students | 4 | 7.3% | 2 | 3.6% | 1 | 1.8% | 17 | 30.9% | 31 | 56.4% |
Fourth-year students | 3 | 3.8% | 6 | 7.5% | 4 | 5.0% | 29 | 36.3% | 38 | 47.5% |
Community | 3 | 4.3% | 3 | 4.3% | 2 | 2.9% | 25 | 35.7% | 37 | 52.9% |
Hospital | 4 | 6.2% | 5 | 7.8% | 3 | 4.6% | 21 | 32.3% | 32 | 49.2% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Papineau, J.H.; Newlon, J.L.; Ades, R.S.; Vernon, V.; Wilkinson, T.A.; Thoma, L.M.; Meredith, A.H. Evaluation of Student Pharmacists’ Attitudes and Perceptions of Hormonal Contraception Prescribing in Indiana. Pharmacy 2021, 9, 185. https://doi.org/10.3390/pharmacy9040185
Papineau JH, Newlon JL, Ades RS, Vernon V, Wilkinson TA, Thoma LM, Meredith AH. Evaluation of Student Pharmacists’ Attitudes and Perceptions of Hormonal Contraception Prescribing in Indiana. Pharmacy. 2021; 9(4):185. https://doi.org/10.3390/pharmacy9040185
Chicago/Turabian StylePapineau, J. Henry, Jenny L. Newlon, Ryan S. Ades, Veronica Vernon, Tracey A. Wilkinson, Lynn M. Thoma, and Ashley H. Meredith. 2021. "Evaluation of Student Pharmacists’ Attitudes and Perceptions of Hormonal Contraception Prescribing in Indiana" Pharmacy 9, no. 4: 185. https://doi.org/10.3390/pharmacy9040185
APA StylePapineau, J. H., Newlon, J. L., Ades, R. S., Vernon, V., Wilkinson, T. A., Thoma, L. M., & Meredith, A. H. (2021). Evaluation of Student Pharmacists’ Attitudes and Perceptions of Hormonal Contraception Prescribing in Indiana. Pharmacy, 9(4), 185. https://doi.org/10.3390/pharmacy9040185